- Telehealth Visits
- Insurance plan information
Line Jacques, MD, MS
Neurosurgery • Pediatric Neurosurgery- Telehealth Visits
- Insurance plan information
Line Jacques, MD, MS
Neurosurgery • Pediatric Neurosurgery- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Neurological Surgery, American Board of Neurological Surgery
Fellowship
- Neurosurgery, Louisiana State University (LSU) - Shreveport GME
Residency
- Neurosurgery, University of Montreal Hospital Saint-Luc
Internship
- General Surgery, St. Luc Hospital
Degree
- MD, Universite de Montreal
My expertise
Specialties
- Neurosurgery
- Pediatric Neurosurgery
Conditions
- Peripheral Nerve Tumors
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%222242%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222242%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 70 reviews
- January 21, 20262.2 out of 5 Stars
4 and 1/2 minutes were spent on me.
- January 20, 20265 out of 5 Stars
Dr. Jaques has been excellent in all aspects from previous thru post surgery. Very kind and effective in guidance. This interest in my recovery has supported awesome results.
- January 17, 20263.4 out of 5 Stars
Like to see care provider demonstrate more care & concern about my conditions. More personal concern.
- January 15, 20265 out of 5 Stars
Dr. Was truly interested in my condition and offered suggestions for continuing care
- December 10, 20255 out of 5 Stars
Excellent
- November 27, 20253 out of 5 Stars
The Dr. Was very short and to the point. I felt rushed during the call. It seemed like she is very busy and didn't have much time to spend.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.